Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells

The so-called shock and kill therapies aim to combine HIV-1 reactivation by latency-reversing agents (LRA) with immune clearance to purge the HIV-1 reservoir. The clinical use of LRA has demonstrated detectable perturbations in the HIV-1 reservoir without measurable reductions to date. Consequently,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz, Alba, Blanch-Lombarte, Oscar, Jimenez-Moyano, Esther, Ouchi, Dan, Mothe, Beatriz, Peña, Ruth, Galvez, Cristina, Genescà, Meritxell, Martinez-Picado, Javier, Goulder, Philip, Barnard, Richard, Howell, Bonnie, Clotet, Bonaventura, Prado, Julia G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349966/
https://www.ncbi.nlm.nih.gov/pubmed/30723480
http://dx.doi.org/10.3389/fimmu.2018.03162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349966/
https://www.ncbi.nlm.nih.gov/pubmed/30723480
http://dx.doi.org/10.3389/fimmu.2018.03162

Ejemplares similares